co-drx.com Open in urlscan Pro
23.254.209.175  Public Scan

Form analysis
0 forms found in the DOM

Text Content

CO-D THERAPEUTICS





NAVIGATION

 * About Co-D
   * Mission & Vision
   * Management
   * Board of Directors
   * Advisory Board
   * Career Opportunities
 * Technology
   * Combination Therapy
 * Pipeline
   * Triolimus
 * Partnering
 * News & Events
   * Co-D in the News
   * Press Releases
   * Events
   * Publications
   * Presentations
 * Contact Us


 * PARTNERING
   
   Co-D is seeking to establish strategic partnerships to develop the company’s
   nano-medicine programs.


 * TECHNOLOGY
   
   Polymeric micelle technology may enhance drug delivery to solid tumors.
   


 * PIPELINE
   
   Triolimus is a 3-in-1 nanomedicine that carries paclitaxel, rapamycin, and
   17-AAG for combination cancer therapy.
   


 * PARTNERING
   
   Co-D is seeking to establish strategic partnerships to develop the company’s
   nano-medicine programs.
   


 * TECHNOLOGY
   
   Polymeric micelle technology may enhance drug delivery to solid tumors.

 1. 1
 2. 2
 3. 3

 * Previous
 * Next

AN INNOVATIVE DRUG DEVELOPMENT COMPANY DEDICATED TO BRINGING TO MARKET
FIRST-IN-CLASS,
COMBINATION NANOMEDICINES WITH HIGH SAFETY PROFILES TO TREAT CANCER


ABOUT US

Co-D Therapeutics, Inc. ("Co-D") was incorporated in response to the unmet
medical need in current cancer therapy and the need to improve patients' lives.
Co-D is an innovative drug development company dedicated to bringing to market
first-in-class, combination nanomedicines with high safety profiles to treat
cancer.

Learn More


 * PARTNERING
   
   We anticipate that Co-D’s platform technology will generate multiple products
   in the future. Co-D is seeking to establish strategic partnerships that are
   aligned with our business strategy to develop the company’s nano-medicine
   programs.
   
   
   Read more
   
   


 * TECHNOLOGY
   
   Co-D Therapeutics’ core polymeric micelle technology offers an array of
   advantages over conventional methods of cancer drug delivery. First,
   polymeric micelles permit the delivery of water-insoluble, hard to deliver,
   cancer drugs in a single, safe vehicle.
   
   
   Read more
   
   


 * PIPELINE
   
   With a core technology that facilitates the safe, effective delivery of
   multiple anti-cancer agents, the Co-D Therapeutics Pipeline is as rich as the
   cancer chemotherapy arsenal itself.
   
   
   Read more
   
   

 * 

Co-D Therapeutics © 2013-2018. All Rights Reserved.
                         Home | About Co-D | Technology | Pipeline | Partnering
| News & Events | Careers | Contact Us